-
公开(公告)号：US20150258093A1
公开(公告)日：2015-09-17
申请号：US14677611
申请日：2015-04-02
Applicant: AbbVie Inc. , AbbVie Deutschland GmbH & Co. KG
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter A. Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable
IPC: A61K31/513 , A61K31/4025 , A61K31/427 , A61K31/497
CPC classification number: A61K31/513 , A61K9/209 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K2300/00
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
Abstract translation: 本公开涉及包含抗病毒化合物的固体剂型和使用这些剂型来治疗抗病毒感染的方法。
-
公开(公告)号：US20170368066A1
公开(公告)日：2017-12-28
申请号：US15639424
申请日：2017-06-30
Applicant: AbbVie Inc.
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable
IPC: A61K31/513 , A61K47/38 , A61K31/4025 , A61K9/24 , A61K31/427 , A61K31/497 , A61K47/32
CPC classification number: A61K31/513 , A61K9/209 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K2300/00
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
-
Patent Agency Ranking
公开(公告)号：US20160199374A1
公开(公告)日：2016-07-14
申请号：US15073767
申请日：2016-03-18
Applicant: AbbVie Inc.
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable
IPC: A61K31/513 , A61K47/38 , A61K31/427 , A61K47/32 , A61K31/497 , A61K31/4025
CPC classification number: A61K31/513 , A61K9/209 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K2300/00
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
-
公开(公告)号：US09744170B2
公开(公告)日：2017-08-29
申请号：US15073767
申请日：2016-03-18
Applicant: AbbVie Inc.
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable
IPC: A61K31/513 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K9/24
CPC classification number: A61K31/513 , A61K9/209 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K2300/00
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
-
公开(公告)号：US10105365B2
公开(公告)日：2018-10-23
申请号：US15639424
申请日：2017-06-30
Applicant: AbbVie Inc.
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable , Susan George
IPC: A61K31/513 , A61K47/38 , A61K9/24 , A61K31/427 , A61K31/497 , A61K47/32 , A61K31/4025
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
-
公开(公告)号：US20170189426A1
公开(公告)日：2017-07-06
申请号：US15466673
申请日：2017-03-22
Applicant: AbbVie Inc.
Inventor： Claudia Packhaeuser , Norbert Steiger , Bernd Liepold , Drazen Kostelac , Martin Knobloch
IPC: A61K31/635 , A61K9/48 , A61K9/00 , A61K9/20
CPC classification number: A61K31/635 , A61K9/0053 , A61K9/146 , A61K9/2013 , A61K9/2027 , A61K9/2095 , A61K9/4833
Abstract: The invention relates to a pharmaceutical dosage form which comprises a solid dispersion product comprising N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl) propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide or a salt, hydrate or solvate thereof, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer. The invention is further directed to processes for preparing the pharmaceutical dosage form and to use of the dosage form for treating proliferative disorders
-
公开(公告)号：US09333204B2
公开(公告)日：2016-05-10
申请号：US14677611
申请日：2015-04-02
Applicant: AbbVie Inc. , AbbVie Deutschland GmbH & Co. KG
Inventor： Jonathan M. Miller , John B. Morris , Nancy E. Sever , Eric A. Schmitt , Ping X. Gao , Yi Shi , Yi Gao , Bernd Liepold , Anna Moosmann , Mirko Pauli , Fatih Durak , Thomas Kessler , Peter A. Hoelig , Karin Rosenblatt , Drazen Kostelac , Rajeev Gokhale , Mark Costello , Carl Knable
IPC: A61K31/4965 , A01N43/54 , A01N43/36 , A61K31/513 , A61K47/32 , A61K47/38 , A61K9/24 , A61K31/4025 , A61K31/427 , A61K31/497
CPC classification number: A61K31/513 , A61K9/209 , A61K31/4025 , A61K31/427 , A61K31/497 , A61K47/32 , A61K47/38 , A61K2300/00
Abstract: The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infection.
Abstract translation: 本公开涉及包含抗病毒化合物的固体剂型和使用这些剂型来治疗抗病毒感染的方法。
-
-
-
-
-
-
Search Results
7
records
(took 0.022 seconds)
